1. Home
  2. IMUX vs ATOM Comparison

IMUX vs ATOM Comparison

Compare IMUX & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • ATOM
  • Stock Information
  • Founded
  • IMUX 2016
  • ATOM 2001
  • Country
  • IMUX United States
  • ATOM United States
  • Employees
  • IMUX N/A
  • ATOM N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • ATOM Semiconductors
  • Sector
  • IMUX Health Care
  • ATOM Technology
  • Exchange
  • IMUX Nasdaq
  • ATOM Nasdaq
  • Market Cap
  • IMUX 110.8M
  • ATOM 100.9M
  • IPO Year
  • IMUX N/A
  • ATOM 2016
  • Fundamental
  • Price
  • IMUX $1.06
  • ATOM $5.79
  • Analyst Decision
  • IMUX Strong Buy
  • ATOM Strong Buy
  • Analyst Count
  • IMUX 5
  • ATOM 1
  • Target Price
  • IMUX $13.20
  • ATOM $7.00
  • AVG Volume (30 Days)
  • IMUX 1.5M
  • ATOM 461.9K
  • Earning Date
  • IMUX 11-07-2024
  • ATOM 10-29-2024
  • Dividend Yield
  • IMUX N/A
  • ATOM N/A
  • EPS Growth
  • IMUX N/A
  • ATOM N/A
  • EPS
  • IMUX N/A
  • ATOM N/A
  • Revenue
  • IMUX N/A
  • ATOM $662,000.00
  • Revenue This Year
  • IMUX N/A
  • ATOM N/A
  • Revenue Next Year
  • IMUX N/A
  • ATOM $2,800.00
  • P/E Ratio
  • IMUX N/A
  • ATOM N/A
  • Revenue Growth
  • IMUX N/A
  • ATOM 13140.00
  • 52 Week Low
  • IMUX $0.97
  • ATOM $2.31
  • 52 Week High
  • IMUX $2.11
  • ATOM $9.19
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 28.31
  • ATOM 69.99
  • Support Level
  • IMUX $1.15
  • ATOM $4.30
  • Resistance Level
  • IMUX $1.28
  • ATOM $7.11
  • Average True Range (ATR)
  • IMUX 0.08
  • ATOM 0.61
  • MACD
  • IMUX -0.01
  • ATOM 0.14
  • Stochastic Oscillator
  • IMUX 12.90
  • ATOM 65.17

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the most widely used transistor type in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, FinFET technology, logic and processors, and SRAM.

Share on Social Networks: